Green Cross eying sales of 10 billion won with new drug

Published: 2012-06-25 06:56:00

Updated: 2012-06-25 06:56:00

Green Cross Corporation one of Korea's largest pharmaceutical companies said Thursday that its Shinbaro capsule, a new natural substance-containing medicine designed to cure degenerative arthritis, is expected to reach 10 billion won in sales this year.

Launched on September last year, it is t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK